Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,310 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06709092Recruiting
Testing Lupatadine for dust mite allergies
This study tests a new tablet (Lupatadine Fumarate) for people with nasal allergies caused by dust mites. It looks at how well the medicine works and what it does in the body.
Nanjing, JiangsuAges 18–65 - NCT07604766RecruitingPhase 3
Rina-S for platinum-resistant ovarian cancer in China
This study tests a new cancer drug called Rina-S (an antibody-drug conjugate, which is a targeted therapy that delivers medicine directly to cancer cells) compared to standard treatment options for ovarian cancer that has returned or worsened after platinum chemotherapy. The trial is specifically for patients in China whose cancer is resistant to platinum drugs.
ChangchunAges 18 years+ - NCT07603895Recruiting
Probiotic treatment for yeast infections
This study tests whether a probiotic product (good bacteria) can help treat vulvovaginal yeast infections alongside standard care. You'll use the probiotic for a set period and report how your symptoms improve.
Torrevieja, AlicanteAges Any age - NCT07610473RecruitingPhase 2
Testing DT-101 as an add-on for depression
This trial tests if a new medication, DT-101, can help when added to your current depression treatment. It's for adults with recurrent depression who may need extra support.
Phoenix, ArizonaAges 18–75 - NCT07607769Recruiting
Tremelimumab and Durvalumab for Untreated Advanced Liver Cancer
This Italian study follows patients with advanced liver cancer (hepatocellular carcinoma) who receive a combination immunotherapy treatment called STRIDE for the first time. The trial tracks how well the treatment works, how it affects quality of life, and its safety in people with moderate to severe liver disease.
AnconaAges 18–100 - NCT07609914RecruitingPhase 4
Safety study of an extra dose of rimegepant for migraine
This study tests whether taking an additional dose of rimegepant (a migraine medicine you may already use) is safe and helpful for adults with migraine. Rimegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist—a type of medicine that blocks a protein involved in migraine pain.
Canoga Park, CaliforniaAges 18 years+ - NCT05598528Recruiting
Study why some lung cancers don’t respond to EGFR pills
This study looks at why certain EGFR-positive advanced lung cancers resist third-generation EGFR tablet treatment given as the first treatment. Your body samples and scan results help researchers understand the resistance, which may guide better future care.
Changsha, HunanAges 18 years+ - NCT04666454RecruitingPhase 4
Medication trial for broken heart (Takotsubo) syndrome
This trial tests an optimized medication approach for people diagnosed with Takotsubo (“broken heart”) syndrome. It may help clinicians find a safer and more effective treatment plan after this heart condition.
AarhusAges 18 years+ - NCT06224426Recruiting
Oxygen Levels for Stroke Patients Having Clot Removal
This trial tests whether giving a specific level of oxygen during a procedure to remove a stroke clot improves recovery. It is for people with a moderate to severe stroke in the front part of the brain, treated within 24 hours of symptoms starting.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07605650Recruiting
Fascia Release Technique for Forward Head Posture
This study tests whether adding a specialized soft-tissue technique (IASTM) to standard physical therapy helps improve forward head posture better than therapy alone. Forward head posture is when your head juts forward, which can cause neck pain and stiffness.
Giza, Giza GovernorateAges 18–30 - NCT07609030Recruiting
Brain Training During CAR-T Cell Cancer Treatment
This study tests whether special brain exercises can help protect thinking and memory skills during CAR-T cell therapy—a newer cancer treatment for certain blood cancers. Researchers want to see if training your brain during treatment reduces side effects on memory and mental function.
Columbus, OhioAges 18 years+ - NCT07609407Recruiting
Pelvic Stability Training After Stroke for Leg Function
This study tests whether special exercises focused on stabilizing your pelvis (hip area) can help improve leg strength and movement after a stroke. The training is designed for people in the early recovery phase who are learning to stand and walk again.
Faisalabad, Punjab ProvinceAges 40–60 - NCT07605715Recruiting
Catheter vs. Surgery for Leaky Mitral Valve
This study compares two ways to fix a leaky mitral valve (a heart valve that doesn't close properly): one using a thin tube inserted through blood vessels (catheter) versus traditional open-heart surgery. The goal is to see which approach works better and is safer for older adults.
Los Angeles, CaliforniaAges 60 years+ - NCT07606625RecruitingPhase 4
Nasal spray for dry eye disease and tear film stability
This study tests whether a nasal spray can improve dry eye symptoms and tear production in people with mild to moderate meibomian gland dysfunction (a common cause of dry eye). You'll use the spray daily while the research team monitors your eye health and comfort over several weeks.
Berkeley, CaliforniaAges 18 years+ - NCT07603804Recruiting
Accelerated Brain Stimulation for Treatment-Resistant Depression
This study tests an accelerated form of iTBS (a non-invasive brain stimulation technique) for depression that hasn't improved with antidepressant medications. The goal is to help people with major depression who haven't responded adequately to at least one antidepressant drug.
IstanbulAges 18–65 - NCT07608939Recruiting
Pain relief after root canal treatment with different sealers
This study compares how much pain you experience after root canal treatment depending on which type of sealing material is used. Root canal treatment removes infected tissue from inside a tooth; this trial helps dentists find the approach that causes the least post-treatment discomfort.
LefkaAges 18–60 - NCT07604103RecruitingPhase 3
Heart Attack and Pneumonia Recovery Study With Vaccination
This study looks at blood markers (special proteins) in patients who have had both a heart attack and pneumonia, to see how vaccination affects recovery. The goal is to understand whether flu and pneumonia vaccines are safe and helpful for people recovering from these two serious conditions together.
Malang, East JavaAges 18–65 - NCT07604740Enrolling by invitation
Does couple therapy help strengthen relationships before baby arrives?
This study tests whether couple counseling helps parents-to-be and blended families in the Helsinki area work through relationship challenges. The researchers want to see if therapy helps couples feel more connected and secure before their first child is born.
HelsinkiAges 18 years+ - NCT07604896RecruitingPhase 4
Lecanemab for early Alzheimer's disease with amyloid buildup
This trial tests lecanemab, an infusion medicine that targets amyloid protein buildup in the brain, in people with mild cognitive impairment or mild Alzheimer's disease. Researchers will track how well it works and study how it affects your body's proteins using advanced lab tests.
Wenzhou, ZhejiangAges 50–90 - NCT07606807RecruitingPhase 3
New clot-busting medication for stroke in the extended time window
This trial tests a new medication called rhTNK-tPA for treating acute ischemic stroke (a clot in the brain) up to 24 hours after symptom onset. The study uses simplified imaging to determine eligibility and aims to help patients recover better outcomes.
GuangzhouAges 18 years+ - NCT07603856RecruitingPhase 2
Combining Immunotherapy and Radiation for Advanced Lung Cancer
This study tests whether adding focused radiation therapy to immunotherapy can help patients with advanced non-small cell lung cancer whose cancer has progressed despite prior immunotherapy. The goal is to see if this combination works better than immunotherapy alone.
Chicago, IllinoisAges 18 years+ - NCT07606755RecruitingPhase 4
Jinfeng Pill for Hot Flashes and Menopause Symptoms
This study tests whether a traditional Chinese medicine called Jinfeng Pill can reduce hot flashes, night sweats, sleep problems, mood changes, and other symptoms during perimenopause (the transition to menopause, typically ages 45–55). Researchers want to see if this treatment works better than standard options.
Wuhan, HubeiAges 45–55 - NCT07610187Recruiting
Online trauma treatment for sexual abuse survivors
This trial tests an online treatment program called Restory that helps people cope with the emotional effects of sexual violence. You will use it from home, and it may help reduce your trauma-related distress.
StockholmAges 18 years+ - NCT07610655Recruiting
Nerve Stimulation to Aid Recovery After Spine Surgery
This study tests whether a small device that gently stimulates a nerve in your neck can help you recover better after lumbar spine surgery. The device may help reduce confusion, depression, and other thinking problems that sometimes occur after surgery.
Chicago, IllinoisAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,310 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.